Igenomix’s Scientific Director participates in Fertility & Sterility’s Journal Club Live

Carlos Simon MD, PhD, Scientific Director of Igenomix, and Product Development Manager Antonio Diez, PhD, took part in Fertility & Sterility’s November 2015 Journal Club Live where they discussed Igenomix’s study published in Fertility & Sterility as a SEMINAL CONTRIBUTION in the September 2015 issue “Mitochondrial DNA content as a viability score in human euploid embryos: Less is better1 […]

First 30 hours, key to knowing whether a human embryo will be chromosomally normal

Prof. Carlos Simon, Scientific Director at Igenomix, is one of the researchers taking part in this study. Scientists from Igenomix, University of Valencia, Stanford University and Oregon Health & Science University (OSHU) have discovered that it is possible to predict if a human embryo is going to be chromosomally normal or abnormal within the first […]

Gene therapy: The solution to avoid or correct mitochondrial diseases

As part of the meetings of Excellence VLC/Campus, organized by the Rey Jaime I Awards Foundation, Igenomix hosted an institutional meeting between Dr. Werner Arber, Nobel Laureate in Medicine 1978 and Prof. Carlos Simon, scientific director of Igenomix and Rey Jaime I award winner in 2011 in the category of Medical Research. Both experts also discussed the systems […]

First 30 hours, key to knowing whether a human embryo will be chromosomally normal

Prof. Carlos Simon, Scientific Director at Igenomix, is one of the researchers taking part in this study. Scientists from Igenomix, University of Valencia, Stanford University and Oregon Health & Science University (OSHU) have discovered that it is possible to predict if a human embryo is going to be chromosomally normal or abnormal within the first […]

MitoScore: Mitochondrial biomarker developed by Igenomix will increase implantation rate of in vitro fertilization

One of the great challenges of in vitro fertilization techniques is to be able to guarantee the viability of the transferred embryos to be implanted into the maternal uterus and be able to give birth to a healthy baby. Taking into account that the mitochondria are responsible for providing most of the energy necessary for […]

IGENOMIX in the media – Test will define the ideal moment in which to implant the embryo

Le Figaro Santé –Thomas Cavaillé “FIV: un test pour définir le moment idéal pour implanter l’embryon”   IVF: Test will define the ideal moment in which to implant the embryo A new test, tested on more than 2,500 patients in 10 countries, could prevent many women having repeated implantation failures during in vitro fertilization. Endometrial […]

Scientific Director of Igenomix, Carlos Simon, receives KY Cha Award for investigation into cellular reprogramming

Igenomix presents an advance in non-invasive embryonic selection with an award-winning research which aims to generate sperm and egg cells by reprogramming skin cells. The research Direct conversion of human somatic cells to meiotic germ-like cells by genetic reprogramming, with the aim of creating sperm and egg cells from patients lacking them by reprogramming the […]